TPWM
HQL

Twelve Points Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

Twelve Points Wealth Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,375
Closed -$172K – 180
2024
Q3 		$172K Hold
11,375
– – 0.05% 176
2024
Q2 		$161K Sell
11,375
-50
-0.4% -$676 0.06% 172
2024
Q1 		$156K Hold
11,425
– – 0.06% 168
2023
Q4 		$154K Sell
11,425
-1,365
-11% -$16.8K 0.07% 159
2023
Q3 		$159K Sell
12,790
-108
-0.8% -$1.42K 0.08% 163
2023
Q2 		$175K Hold
12,898
– – 0.09% 159
2023
Q1 		$180K Sell
12,898
-190
-1% -$2.72K 0.1% 157
2022
Q4 		$186K Sell
13,088
-425
-3% -$6.16K 0.13% 157
2022
Q3 		$185K Hold
13,513
– – 0.14% 152
2022
Q2 		$192K Hold
13,513
– – 0.15% 155
2022
Q1 		$224K Sell
13,513
-1,505
-10% -$25.9K 0.17% 162
2021
Q4 		$289K Buy
+15,018
New +$302K 0.23% 133

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Twelve Points Wealth Management's HQL Position: Q4 2024 in Review

Twelve Points Wealth Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 11,375 shares — an estimated $172K sold.

Twelve Points Wealth Management first reported a position in HQL in Q4 2021 and held it in 12 quarters. The position peaked at $289K in Q4 2021. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.

  • Twelve Points Wealth Management reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
  • Twelve Points Wealth Management sold 11,375 abrdn Life Sciences Investors shares in Q4 2024, an estimated $172K.
  • Twelve Points Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2021 and held it in 12 quarters.
  • Twelve Points Wealth Management's abrdn Life Sciences Investors position peaked at $289K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.

Based on Twelve Points Wealth Management's 13F filing for Q4 2024, filed 23 Jan 2025.